Controlled fermentation
A proprietary yeast platform provides a controlled biological starting point for repeatable chitosan production.
MYKITO SCIENCESChitoGene uses recombinant yeast and proprietary fermentation to create high-purity, repeatable non-animal chitosan for demanding medical and pharmaceutical development pathways.
ChitoGene starts with a secure, consistent biological source and adds molecular, endotoxin and bioabsorbability control around the intended application.

CHITOGENE ADVANTAGES
A proprietary yeast platform provides a controlled biological starting point for repeatable chitosan production.
Master-cell-line control and documented processing support high-purity material, reproducibility and complete batch traceability.
EndoFree and ABC pathways extend the platform toward low-endotoxin and absorbable, biocompatible material development.
COMPARE THE PLATFORMS